EXPD vs PPCB · P/E 26, rev $10.60B vs P/E 0.0, $3.9M cap
Expeditors International of Washington, Inc. (EXPD) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
PPCB does not have a complete income-statement cache yet.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the EXPD and PPCB stock pages for the full models.
Not investment advice.